» Articles » PMID: 37922063

Polyphenols Targeting MAP Kinase Signaling Pathway in Neurological Diseases: Understanding Molecular Mechanisms and Therapeutic Targets

Abstract

Polyphenols are a class of secondary metabolic products found in plants that have been extensively studied for how well they regulate biological processes, such as the proliferation of cells, autophagy, and apoptosis. The mitogen-activated protein kinase (MAPK)-mediated signaling cascade is currently identified as a crucial pro-inflammatory pathway that plays a significant role in the development of neuroinflammation. This process has been shown to contribute to the pathogenesis of several neurological conditions, such as Alzheimer's disease (AD), Parkinson's disease (PD), CNS damage, and cerebral ischemia. Getting enough polyphenols through eating habits has resulted in mitigating the effects of oxidative stress (OS) and lowering the susceptibility to associated neurodegenerative disorders, including but not limited to multiple sclerosis (MS), AD, stroke, and PD. Polyphenols possess significant promise in dealing with the root cause of neurological conditions by modulating multiple therapeutic targets simultaneously, thereby attenuating their complicated physiology. Several polyphenolic substances have demonstrated beneficial results in various studies and are presently undergoing clinical investigation to treat neurological diseases (NDs). The objective of this review is to provide a comprehensive summary of the different aspects of the MAPK pathway involved in neurological conditions, along with an appraisal of the progress made in using polyphenols to regulate the MAPK signaling system to facilitate the management of NDs.

Citing Articles

Oxidative stress and inflammation in the pathogenesis of neurological disorders: Mechanisms and implications.

Dash U, Bhol N, Swain S, Samal R, Nayak P, Raina V Acta Pharm Sin B. 2025; 15(1):15-34.

PMID: 40041912 PMC: 11873663. DOI: 10.1016/j.apsb.2024.10.004.


Targeting natural antioxidant polyphenols to protect neuroinflammation and neurodegenerative diseases: a comprehensive review.

Jalouli M, Rahman M, Biswas P, Rahman H, Harrath A, Lee I Front Pharmacol. 2025; 16:1492517.

PMID: 39981183 PMC: 11840759. DOI: 10.3389/fphar.2025.1492517.


Unlocking the Neuroprotective Potential of Silymarin: A Promising Ally in Safeguarding the Brain from Alzheimer's Disease and Other Neurological Disorders.

Almutary A, Begum M, Siddiqua A, Gupta S, Chauhan P, Wadhwa K Mol Neurobiol. 2025; .

PMID: 39956886 DOI: 10.1007/s12035-024-04654-y.


Characterizing Chemokine Signaling Pathways and Hub Genes in Calcium Oxalate-Induced Kidney Stone Formation: Insights from Rodent Models.

Wang B, Tan Z, She W, Wang X, Guan X, Tao Z Biochem Genet. 2025; .

PMID: 39893356 DOI: 10.1007/s10528-025-11036-z.


Interrelation of Natural Polyphenol and Fibrosis in Diabetic Nephropathy.

Ma Y, Wang J, Fan J, Jia H, Li J Molecules. 2025; 30(1).

PMID: 39795078 PMC: 11722366. DOI: 10.3390/molecules30010020.


References
1.
Ebrahimi A, Schluesener H . Natural polyphenols against neurodegenerative disorders: potentials and pitfalls. Ageing Res Rev. 2012; 11(2):329-45. DOI: 10.1016/j.arr.2012.01.006. View

2.
Davis R . Signal transduction by the JNK group of MAP kinases. Cell. 2000; 103(2):239-52. DOI: 10.1016/s0092-8674(00)00116-1. View

3.
Geest C, Coffer P . MAPK signaling pathways in the regulation of hematopoiesis. J Leukoc Biol. 2009; 86(2):237-50. DOI: 10.1189/jlb.0209097. View

4.
Wagner E, Nebreda A . Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer. 2009; 9(8):537-49. DOI: 10.1038/nrc2694. View

5.
Cuadrado A, Nebreda A . Mechanisms and functions of p38 MAPK signalling. Biochem J. 2010; 429(3):403-17. DOI: 10.1042/BJ20100323. View